We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Experts believe bacteriophages could be crucial extra tool
Multiple deficiencies across the health service may cause ICS overhaul to founder
Genome sequencing company paid firms $14.6mn over past two years to try to sway lawmakers
Government appears unwilling to meet demands for higher wages in current financial year
New ways of working are vital but ultimately the UK health service simply needs more cash, experts say
Ruling by US court will make companies think twice about using Chapter 11 schemes to handle lawsuits
The UK’s national health system is showing signs of frailty as it nears its 75th birthday
CS Venkatakrishnan gives his personal account of leading the bank while undergoing care for non-Hodgkin lymphoma
Researchers say device developed in London could help thousands suffering from vascular disease
Chief executive Paul Hudson sounds the alarm over British government’s cuts to research
UK drugmaker’s shingles vaccine boosts sales while demand for Covid-related products falls
The industry is under pressure from increasing wages after loading up on leveraged loans
US drugmaker expects revenues of between $67bn and $71bn this year, down from a record
Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch
Ruling from US appeals court casts doubt on future of contentious ‘Texas two-step’ manoeuvre
Blueprint relies on ‘virtual’ wards and improved community care to alleviate bottlenecks
DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators
UK biotech racing to keep antibody up to date with latest variants
Shortage of doctors with university posts is putting health service on ‘dangerous precipice’
Short-termism and suspicion in parts of government risk our valuable future in precision medicine
Tight budgets and US reforms are ending a truce between the industry and health authorities
Ubben believes more could be done to isolate the liability to Roundup
Officials row with Pfizer over price as villages struggle to obtain antiviral medication
Beijing’s push to boost the sector has been undermined by reimbursement rules
International Edition
